Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats

Brain Research

Volumn 1203, Issue , 2008, Pages 170-176

  Fujita, Youshi ^a   Lin, J Xi ^a   Takahashi, Ryosuke ^a   Tomimoto, Hidekazu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cilostazol; Phenotypic modulation; Small vessel disease; Stroke prone spontaneously hypertensive rat; Vascular smooth muscle cell; White matter

Indexed keywords

CILOSTAZOL; MYOSIN HEAVY CHAIN; SMOOTH MUSCLE ACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN DAMAGE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STROKE; VASCULAR FIBROSIS; WHITE MATTER;

ACTINS; ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; MALE; MUSCLE, SMOOTH, VASCULAR; NEUROGLIA; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STROKE; TETRAZOLES;

RATTUS;

EID: 40949098993     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.01.103     Document Type: Article

References (42)

1. Aikawa M., Sivam P.N., Kuro-o M., Kimura K., Nakahara K., Takewaki S., Ueda M., Yamaguchi H., Yazaki Y., Periasamy M., and Nagai R. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ. Res. 73 (1993) 1000-1012
2. Aikawa M., Sakomura Y., Ueda M., Kimura K., Manabe I., Ishiwata S., Komiyama N., Yamaguchi H., Yazaki Y., and Nagai R. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 96 (1997) 82-90
3. Akishita M., Iwai M., Wu L., Zhang L., Ouchi Y., Dzau V.J., and Horiuchi M. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 102 (2000) 1684-1689
4. Baumbach G.L., and Heistad D.D. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 13 (1989) 968-972
5. Chamley-Campbell J., Campbell G.R., and Ross R. The smooth muscle cell in culture. Physiol. Rev. 59 (1979) 1-61
6. Cipolla M.J., DeLance N., and Vitullo L. Pregnancy prevents hypertensive remodeling of cerebral arteries: a potential role in the development of eclampsia. Hypertension 47 (2006) 619-626
7. Contard F., Sabri A., Glukhova M., Sartore S., Marotte F., Pomies J.P., Schiavi P., Guez D., Samuel J.L., and Rappaport L. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 22 (1993) 665-676
8. Dawson D.L., Cutler B.S., Meissner M.H., and Strandness Jr. D.E. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98 (1998) 678-686
9. Fetalvero K., Shyu M., Nomikos A.P., Chiu Y.F., Wagner R.J., Powell R.J., Hwa J., and Martin K.A. The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1337-H1346
10. Fisher C.M. The arterial lesions underlying lacunes. Acta Neuropathol. (Berl.) 12 (1968) 1-15
11. Fredriksson K., Nordborg C., Kalimo H., Olsson Y., and Johansson B.B. Cerebral microangiopathy in stroke-prone spontaneously hypertensive rats. An immunohistochemical and ultrastructural study. Acta Neuropathol. (Berl.) 75 (1988) 241-252
12. Gotoh F., Tohgi H., Hirai S., Terashi A., Fukuuchi Y., Otomo E., Shinohara Y., Itoh E., Matsuda T., Sawada T., Yamaguchi T., Nishimaru K., and Ohashi Y. Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J. Stroke Cerebrovasc. Dis. 9 (2000) 147-157
13. Grünwald J., and Haudenschild C.C. Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro. Arteriosclerosis 4 (1984) 183-188
14. Hart M.N., Heistad D.D., and Brody M.J. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 2 (1980) 419-423
15. Hashimoto A., Miyakoda G., Hirose Y., and Mori T. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189 (2006) 350-357
16. Hazama F., Chue C.H., Kataoka H., Sasahara M., and Amano S. Pathogenesis of lacuna-like cyst formation and diffuse degeneration of the white matter in the brain of stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl. 22 (1995) S260-S261
17. Intengan H.D., and Schiffrin E.L. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38 (2001) 581-587
18. Izzard A.S., Rizzoni D., Agabiti-Rosei E., and Heagerty A.M. Small artery structure and hypertension: adaptive changes and target organ damage. J. Hypertens. 23 (2005) 247-250
19. Johansson B.B., and Fredriksson K. Cerebral arteries in hypertension: structural and hemodynamic aspects. J. Cardiovasc. Pharmacol. 7 Suppl 2 (1985) S90-S93
20. Kalaria R.N., Kenny R.A., Ballard C.G., Perry R., Ince P., and Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J. Neurol. Sci. 226 (2004) 75-80
21. Katayama Y., Katsumata T., Muramatsu H., Usuda K., Obo R., and Terashi A. Effect of long-term administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP). Brain Res. 761 (1997) 300-305
22. Kimura Y., Tani T., Kanbe T., and Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforschung 35 (1985) 1144-1149
23. Kocher O., Gabbiani F., Gabbiani G., Reidy M.A., Cokay M.S., Peters H., and Huttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab. Invest. 65 (1991) 459-470
24. Lee J.H., Park S.Y., Shin Y.W., Hong K.W., Kim C.D., Sung S.M., Kim K.Y., and Lee W.S. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion. Brain Res. 1082 (2006) 182-191
25. Lin J.X., Tomimoto H., Akiguchi I., Matsuo A., Wakita H., Shibasaki H., and Budka H. Vascular cell components of the medullary arteries in Binswanger's disease brains: a morphometric and immunoelectron microscopic study. Stroke 31 (2000) 1838-1842
26. Lin J.X., Tomimoto H., Akiguchi I., Wakita H., Shibasaki H., and Horie R. White matter lesions and alteration of vascular cell composition in the brain of spontaneously hypertensive rats. Neuroreport 12 (2001) 1835-1839
27. Nakamura K., Ikomi F., and Ohhashi T. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles. J. Vasc. Res. 43 (2006) 86-94
28. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84 (2004) 767-801
29. Pantoni L., and Garcia J.H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 26 (1995) 1293-12301
30. Park S.Y., Lee J.H., Kim C.D., Lee W.S., Park W.S., Han J., Kwak Y.G., Kim K.Y., and Hong K.W. Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. J. Pharmacol. Exp. Ther. 317 (2006) 1238-1245
31. Pauletto P., Da Ros S., Capriani A., Chiavegato A., Pessina A.C., and Sartore S. Smooth muscle cell types at different aortic levels and in microvasculature of rabbits with renovascular hypertension. J. Hypertens. 13 (1995) 1679-1685
32. Puato M., Faggin E., Favaretto E., Bertipaglia B., Rattazzi M., Rizzoni D., Gamba G.P., Sartore S., Rosei E.A., Pessina A.C., and Pauletto P. Prevalence of fetal-type smooth muscle cells in the media of microvessels from hypertensive patients. Hypertension 44 (2004) 191-194
33. Rizzoni D., Porteri E., Boari G.E., De Ciuceis C., Sleiman I., Muiesan M.L., Castellano M., Miclini M., and Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 108 (2003) 2230-2235
34. Roman G.C., Erkinjuntti T., Wallin A., Pantoni L., and Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol. 1 (2002) 426-436
35. Saito H., Togashi H., Yoshioka M., Nakamura N., Minami M., and Parvez H. Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl. 22 (1995) S257-S259
36. Sjolund M., Madsen K., von der Mark K., and Thyberg J. Phenotype modulation in primary cultures of smooth-muscle cells from rat aorta. Synthesis of collagen and elastin. Differentiation 32 (1986) 173-180
37. van Swieten J.C., Geyskes G.G., Derix M.M., Peeck B.M., Ramos L.M., van Latum J.C., and van Gijn J. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann. Neurol. 30 (1991) 825-830
38. Wakita H., Tomimoto H., Akiguchi I., and Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol. (Berl.) 87 (1994) 484-492
39. Wakita H., Tomimoto H., Akiguchi I., Lin J.X., Ihara M., Ohtani R., and Shibata M. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res. 992 (2003) 53-59
40. Watanabe T., Zhang N., Liu M., Tanaka R., Mizuno Y., and Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 37 (2006) 1539-1545
41. Yamori Y., and Horie R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 8 (1977) 456-461
42. Yanagihara T. Vascular dementia in Japan. Ann. N. Y. Acad. Sci. 977 (2002) 24-28